1-6 of 6
Kazimierz Kuliczkowski, MD PhD Prof.
Close
Sort by
Journal Articles

Ofatumumab (OFA) Maintenance Prolongs PFS in Relapsed CLL: Prolong Study Interim Analysis Results

Marinus H.J. van Oers, Kazimierz Kuliczkowski, MD PhD Prof., Lukas Smolej, Mario Petrini, Fritz Offner, Sebastian Gorsicki, Mark-David Levin, Ira Gupta, Jennifer Phillips, Vanessa Williams, Steen Lisby, Christian Geisler
Journal: Blood
Blood (2014) 124 (21): 21.
https://doi.org/10.1182/blood.V124.21.21.21
Published: 2014
Journal Articles

The Hasford Score Correlates with the Long-Term Molecular Response to Imatinib Treatment for Chronic Myeloid Leukemia Patients and May be Useful for Differentiating Low and Intermediate Risk Patients: A Single Institution Experience

Jaroslaw Dybko, MD PhD, Ewa Medras, MD, Olga Haus, MD PhD, Bozena Jazwiec, MSC, Tomasz Wrobel, MDPhD, Kazimierz Kuliczkowski, MD PhD Prof.
Journal: Blood
Blood (2014) 124 (21): 3152.
https://doi.org/10.1182/blood.V124.21.3152.3152
Published: 2014
Journal Articles

High Expression of Mir-15a Predicts Shorter Survival and Worse Response to Chemotherapy in Patients with Acute Myeloid Leukemia (AML)

Aleksandra Butrym, MD PhD, Dagmara Baczynska, PhD, Andrzej Tukiendorf, Prof., Justyna Rybka, MD PhD, Tadeusz Dobosz, Prof., Wojciech Jurczak, Kazimierz Kuliczkowski, MD PhD Prof., Grzegorz Mazur, Prof.
Journal: Blood
Blood (2014) 124 (21): 5330.
https://doi.org/10.1182/blood.V124.21.5330.5330
Published: 2014
Journal Articles

Once-Weekly Prophylactic Treatment Versus on-Demand Treatment of Nonacog Alfa in Patients with Moderately Severe to Severe Hemophilia B

Kaan Kavakli, Lynne Smith, Kazimierz Kuliczkowski, MD PhD Prof., Joan Korth-Bradley, Chur Woo You, Joanne Fuiman, Silva Zupancic-Salek, Faraizah Abdul Karim, Pablo Rendo
Journal: Blood
Blood (2014) 124 (21): 1523.
https://doi.org/10.1182/blood.V124.21.1523.1523
Published: 2014
Journal Articles

Role of Second Stem Cell Transplantation in Relapsed Lymphoproliferative Diseases: Remission Status Is the Most Important Factor Predicting the Outcome

Lidia Gil, MD PhD, Jan Styczynski, MD, PhD, Agnieszka Piekarska, MD PhD, Beata Jakubas, MD PhD, Katarzyna Drabko, MD PhD, Tomasz Wrobel, prof., Anna Czyz, MD PhD, Anna Lojko-Dankowska, MD PhD, Dominik Dytfeld, MD PhD, Adam Nowicki, MD, Patrycja Mensah-Glanowska, MD PhD, Wanda Knopinska-Posluszny, MD, PhD, Maria Bieniaszewska, MD PhD, Mariusz Wysocki, MD, PhD, Andrzej Hellmann, MD, PhD, Aleksander Skotnicki, Jerzy Kowalczyk, Kazimierz Kuliczkowski, MD PhD, prof., Mieczyslaw Komarnicki, MD PhD
Journal: Blood
Blood (2011) 118 (21): 3109.
https://doi.org/10.1182/blood.V118.21.3109.3109
Published: 2011
Journal Articles

High Expression of Haematopoietic Cell Specyfic Lyn Substrate-1 (HS1) Predicts Survival of B-Cell Chronic Lymphocytic Leukemia Patients

Aleksandra Butrym, MD, PhD, Miroslaw Majewski, MD, Justyna Dzietczenia, MD, PhD, Tomasz Wrobel, prof., Kazimierz Kuliczkowski, MD PhD, prof., Grzegorz Mazur, prof.
Journal: Blood
Blood (2011) 118 (21): 2853.
https://doi.org/10.1182/blood.V118.21.2853.2853
Published: 2011